Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites-Reference-Cited by-同舟云学术

Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites

Published:2024-10 Issue: Volume:276 Page:116669
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Trotta Anna Maria,Tomassi Stefano,Di Maiolo Gaetana,Ieranò Caterina,Vetrei Cinzia,D'Alterio Crescenzo,Merlino Francesco,Messere Anna,D'Aniello Antonia,Del Bene Alessandra,Mazzarella Vincenzo,Roggia Michele,Natale Benito,Cutolo Roberto,Campagna Erica,Mottola Salvatore,Russo Rosita,Chambery Angela,Benedetti Rosaria,Altucci Lucia,Cosconati Sandro,Scala Stefania,Di Maro Salvatore^ORCID

Funder

Ministero dello Sviluppo Economico

Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca

Ministero della Salute

Publisher

Elsevier BV

Reference61 articles.

1. The chemokine system in innate immunity;Sokol;Cold Spring Harbor Perspect. Biol.,2015

2. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation;Singh;Stem Cell.,2020

3. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha;Salcedo;Am. J. Pathol.,1999

4. CXCR4 regulates interneuron migration in the developing neocortex;Stumm;J. Neurosci.,2003

5. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor;Feng;Science,1996